NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006
Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 188s Year: 2006
Right heart function and hypoxemia in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 64s Year: 2005
The influence of right ventricular diastolic functions and pulmonary hypertension on exercise limitation and their relationship with serum NT-proBNP levels in COPD Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011
Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Exercise testing confirms the role of impaired central circulatory function and elevated right ventricular stroke work index in patients undergoing lung transplantation Source: Annual Congress 2012 - Lung, heart, muscles and brain: the pathway of oxygen during exercise in health and COPD Year: 2012
Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007
Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
Is there benefit from proactive case-detection of left ventricular systolic dysfunction (LVSD) using BNP in patients with advanced COPD? Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
NT-proBNP correlates with RVEF in patients suffering from pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 110s Year: 2004
Association between right heart failure and endothelial dysfunction in COPD patients Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020
The characterization of diastolic function of the right ventricle in patients with COPD combined with congestive heart failure (CHF) Source: International Congress 2014 – Predictors Year: 2014
NT-proBNP accurately reflects the impact of severe COPD exacerbation on the right ventricle (RV) Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
Plasma levels of NT-proBNP in OSAS patients before CPAP treatment. Relationship to ventricular dysfunction. Preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Right and left ventricular dysfunction in patients with COPD and heart failure Source: Eur Respir J 2007; 30: Suppl. 51, 706s Year: 2007
The correlation of echocardiographic findings with BNP, blood uric acid and CPR in OSAS patients with manifest right cardiac pathologies Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012